Skip to main content
Log in

Inappropriate prescribing in elderly increases costs and AEs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2014 euros

  2. potentially inappropriate prescribing

Reference

  • Moriarty F, et al. Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models. BMJ Open : 30 Jan 2019. Available from: URL: http://dx.doi.org/10.1136/bmjopen-2018-021832

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inappropriate prescribing in elderly increases costs and AEs. PharmacoEcon Outcomes News 822, 15 (2019). https://doi.org/10.1007/s40274-019-5667-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5667-2

Navigation